Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular augmented reality interactive entertainment games and toys in China, today announced the July 30, 2019 closing of its underwritten initial public…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced it has initiated the first phase of branding its lead drug candidate, Oncoprex(TM) immunogene therapy, and has completed and submitted non-proprietary drug name selections to…
PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized bioavailability CBD sales are projected to reach $89 billion by 2024 with a…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today reported on its existing technology licensees that have entered definitive contracts to use its revolutionary DehydraTECH(TM) absorption technology within their existing…
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF), a lifestyle-oriented cannabis company, on Monday announced an amendment to the share purchase agreement dated June 3, 2019 with Spring Oaks Greenhouses, Inc. Per the amended agreement, GGBXF…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, recently obtained approval from Health Canada for the licensing of all of the company’s Phase 4A buildout plans,…
California-based INmune Bio is developing therapies to battle cancers and Alzheimer’s disease by more effectively engaging the body’s own natural defenses Research published in a peer-reviewed scientific journal shows a mechanism by which scientists can…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, remains dedicated to maintaining its high standards in the midst of a growing cannabis supply gap. An article discussing the…
China’s AR industry is estimated at RMB$55 billion in 2020 Favorable Chinese government policies emphasize research and development of new technologies such as AR Few direct competitors in China create exceptional potential for AR application…
Organigram’s proprietary nano-emulsion technology is expected to provide an initial onset of effects within 10 to 15 minutes for cannabis beverages The company’s shelf-stable, thermally stable, water-compatible and palatable cannabinoid nano-emulsion formulation allows for the…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has entered into an advance payment and purchase agreement with 703454 N.B. Inc.…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the initial sale of its revolutionary BaroShear(TM)…
ETST subsidiary CTI is engaged in the research and development of cannabidiol The company has partnered with Canna Inno Laboratories Inc. to strengthen its foothold in the Canadian CBD market ETST’s Earth Science Pharma is…
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Director of Neuroscience, C.J. Barnum, and Co-Founder and CEO,…
Cannabis users have historically preferred to inhale smoke from the burned plant in order to achieve rapid-onset absorption of its properties, but Lexaria Bioscience is making it possible to achieve similar results through oral ingestion…
ETST stock recently caught the attention of InvestorPlace analyst Mark Putrino Putrino noted in an article that ETST stock stands out, because the company’s management team and advisory board exhibit impressive business experience ETST was…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced a multi-faceted expansion of its relationship with Hill Street Beverage Company Inc. (TSX.V: BEER). According to the update, the companies…
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An…
As the legal marijuana industry continues to rapidly expand, regulatory bodies in the U.S. and other parts of the world are facing lobby pressure to ensure widespread adoption Companies like Lexaria Bioscience have opposed such…